224.06

0.81% 1.799

Iqvia Holdings Inc (IQV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$222.26

Aprire:

$224.05

Volume 24 ore:

703.46K

Relative Volume:

0.47

Capitalizzazione di mercato:

$38.16B

Reddito:

$15.90B

Utile/perdita netta:

$1.28B

Rapporto P/E:

30.76

EPS:

7.2842

Flusso di cassa netto:

$2.21B

1 W Prestazione:

+0.22%

1M Prestazione:

+1.56%

6M Prestazione:

+42.81%

1 anno Prestazione:

+12.56%

Intervallo 1D:

$220.88

$224.53

Intervallo di 1 settimana:

$217.86

$226.76

Portata 52W:

$134.65

$234.29

Iqvia Holdings Inc Stock (IQV) Company Profile

Nome

Iqvia Holdings Inc

Settore

Healthcare (1126)

Industria

Diagnostics & Research (53)

Telefono

919-998-2000

Indirizzo

2400 ELLIS ROAD, DURHAM, NC

Dipendente

91,000

Cinguettio

@IQVIA_global

Prossima data di guadagno

2025-07-22

Ultimi documenti SEC

IQV's Discussions on Twitter

Confronta IQV con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IQV Iqvia Holdings Inc	224.06	37.85B	15.90B	1.28B	2.21B	7.2842
TMO Thermo Fisher Scientific Inc	574.77	215.01B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	227.42	159.87B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	698.52	56.23B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	140.42	39.54B	6.95B	1.30B	1.15B	4.5714

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-11-13	Iniziato	BMO Capital Markets	Outperform
2025-11-03	Downgrade	TD Cowen	Buy → Hold
2025-10-29	Aggiornamento	Robert W. Baird	Neutral → Outperform
2025-10-09	Aggiornamento	HSBC Securities	Hold → Buy
2025-09-09	Aggiornamento	Jefferies	Hold → Buy
2025-04-25	Downgrade	HSBC Securities	Buy → Hold
2025-04-10	Downgrade	Barclays	Overweight → Equal Weight
2025-02-03	Downgrade	BTIG Research	Buy → Neutral
2024-12-20	Iniziato	Stephens	Overweight
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-09-04	Iniziato	RBC Capital Mkts	Outperform
2024-07-24	Downgrade	Jefferies	Buy → Hold
2024-06-06	Iniziato	Goldman	Buy
2024-02-26	Iniziato	Leerink Partners	Outperform
2024-02-15	Downgrade	Guggenheim	Buy → Neutral
2024-02-13	Iniziato	BTIG Research	Buy
2023-11-02	Downgrade	Robert W. Baird	Outperform → Neutral
2023-09-06	Iniziato	HSBC Securities	Buy
2023-03-17	Iniziato	Truist	Buy
2022-12-06	Iniziato	Cowen	Outperform
2022-11-17	Downgrade	Citigroup	Buy → Neutral
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-15	Iniziato	SVB Leerink	Outperform
2022-05-24	Iniziato	Guggenheim	Buy
2022-04-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-04-16	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-03-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Iniziato	Barclays	Overweight
2020-07-07	Iniziato	Stephens	Equal-Weight
2020-03-02	Iniziato	Deutsche Bank	Buy
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Buy
2019-12-13	Aggiornamento	CFRA	Sell → Hold
2019-11-14	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2019-06-21	Aggiornamento	Mizuho	Neutral → Buy
2019-05-28	Iniziato	SVB Leerink	Outperform
2019-01-18	Aggiornamento	Jefferies	Hold → Buy
2018-10-09	Iniziato	UBS	Buy
2018-10-02	Reiterato	Robert W. Baird	Outperform
2018-07-25	Aggiornamento	BofA/Merrill	Neutral → Buy
2018-07-25	Reiterato	Stifel	Buy
2018-07-03	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-04-13	Aggiornamento	Goldman	Neutral → Buy
2018-03-07	Aggiornamento	SunTrust	Hold → Buy
2018-01-19	Iniziato	Evercore ISI	Outperform

Mostra tutto

Iqvia Holdings Inc Borsa (IQV) Ultime notizie

09:53 AM

Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating - marketscreener.com

09:53 AM

Dec 14, 2025

Did IQVIA’s (IQV) Debt Refinancing and Lower SOFR Costs Just Shift Its Investment Narrative? - simplywall.st

Dec 14, 2025

IQVIA’s Strategic Moves and Strong Results Fuel Analyst Confidence - AD HOC NEWS

Dec 14, 2025

Lazard Asset Management LLC Acquires 107,500 Shares of IQVIA Holdings Inc. $IQV - MarketBeat

Dec 14, 2025

Electronic Clinical Outcome Assessment Solutions Market Projected to Reach USD 5.64 Billion by 2032 at a CAGR of 15.3% - GlobeNewswire Inc.

Dec 14, 2025

Dec 13, 2025

Bellevue Group AG Sells 27,368 Shares of IQVIA Holdings Inc. $IQV - MarketBeat

Dec 13, 2025

Dec 12, 2025

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.62 Million Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat

Dec 12, 2025